Understanding immune responses to develop vaccines and treatments for infectious diseases
NIH TETRAMER CORE FACILITY FOR INFECTIOUS DISEASES
This study is all about learning how our immune system fights infections so that we can create better vaccines and treatments, which could help everyone stay healthier in the future.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-11060158 on NIH RePORTER |
What this research studies
This research focuses on enhancing our understanding of how the immune system responds to infectious diseases, which is crucial for developing effective vaccines and therapeutic agents. The project supports the MHC Tetramer Core facility, which synthesizes and distributes specialized reagents to researchers worldwide. By providing these resources, the research aims to facilitate advancements in the prevention and treatment of infectious and immune-mediated diseases. Patients may benefit indirectly through improved public health outcomes and new treatment options that arise from this research.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals affected by infectious diseases or those at high risk of infection.
Not a fit: Patients with non-infectious diseases or those not affected by immune-mediated conditions may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new vaccines and therapies that improve prevention and treatment of infectious diseases.
How similar studies have performed: Previous research has shown success in developing vaccines and therapies through similar approaches, indicating a promising potential for this project.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Altman, John — Emory University
- Study coordinator: Altman, John
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.